MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

13 hedge funds and large institutions have $1.46M invested in Stealth BioTherapeutics Corp. ADS in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$716K
2
+$75K
3
+$67K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$41K
5
Citadel Advisors
Citadel Advisors
Florida
+$31.9K

Top Sellers

1
-$346K
2
-$23K
3
-$10.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$849K
2
$262K
3
$75K
4
$67K
5
$57K
6
$50K
7
$41K
8
$22K
9
$22K
10
$9K
11
$4K
12
$1K
13
$1K
14
–
15
–